Stephen D’Amico

482 total citations
19 papers, 353 citations indexed

About

Stephen D’Amico is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Stephen D’Amico has authored 19 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Stephen D’Amico's work include Pancreatic and Hepatic Oncology Research (6 papers), Phagocytosis and Immune Regulation (3 papers) and Pelvic floor disorders treatments (2 papers). Stephen D’Amico is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Phagocytosis and Immune Regulation (3 papers) and Pelvic floor disorders treatments (2 papers). Stephen D’Amico collaborates with scholars based in United States, Chile and South Korea. Stephen D’Amico's co-authors include Nancy C. Reich, Oleksi Petrenko, William F. Collins, Jinyu Li, Irene Ischenko, Manisha Rao, Michael J. Hayman, Scott Powers, Howard C. Crawford and Benjamin L. Martin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Stephen D’Amico

19 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen D’Amico United States 9 140 119 67 56 48 19 353
Elisabetta Andermarcher Italy 8 45 0.3× 337 2.8× 36 0.5× 26 0.5× 19 0.4× 8 531
Wenzhong Zhu China 11 38 0.3× 153 1.3× 12 0.2× 24 0.4× 109 2.3× 22 317
Eva Schmidt Germany 8 40 0.3× 109 0.9× 63 0.9× 22 0.4× 13 0.3× 14 299
Claudio Catalani Italy 12 56 0.4× 177 1.5× 29 0.4× 80 1.4× 30 0.6× 25 442
Marta Szybowska Canada 10 45 0.3× 261 2.2× 9 0.1× 19 0.3× 23 0.5× 17 510
Yi-Chien Yang Taiwan 11 49 0.3× 118 1.0× 9 0.1× 19 0.3× 50 1.0× 19 290
Hesong Jiang China 11 16 0.1× 201 1.7× 75 1.1× 21 0.4× 169 3.5× 17 447
Christopher W. Perrett United Kingdom 11 24 0.2× 130 1.1× 46 0.7× 11 0.2× 15 0.3× 22 360
Maryline Favier France 10 27 0.2× 341 2.9× 17 0.3× 32 0.6× 29 0.6× 14 509
Qiu-Jie Zhao China 5 54 0.4× 148 1.2× 16 0.2× 67 1.2× 86 1.8× 5 371

Countries citing papers authored by Stephen D’Amico

Since Specialization
Citations

This map shows the geographic impact of Stephen D’Amico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D’Amico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D’Amico more than expected).

Fields of papers citing papers by Stephen D’Amico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D’Amico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D’Amico. The network helps show where Stephen D’Amico may publish in the future.

Co-authorship network of co-authors of Stephen D’Amico

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D’Amico. A scholar is included among the top collaborators of Stephen D’Amico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D’Amico. Stephen D’Amico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
D’Amico, Stephen, Jingxuan Liu, Zhijuan Qiu, et al.. (2025). STAT3 sustains tumorigenicity following mutant KRAS ablation. EMBO Reports. 26(20). 4900–4922. 1 indexed citations
2.
Petrenko, Oleksi, et al.. (2024). Intratumor heterogeneity in KRAS signaling shapes treatment resistance. iScience. 28(2). 111662–111662. 1 indexed citations
3.
D’Amico, Stephen, et al.. (2024). STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer. eLife. 13. 2 indexed citations
4.
D’Amico, Stephen, et al.. (2024). STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer. eLife. 13. 5 indexed citations
5.
D’Amico, Stephen, et al.. (2023). Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease. Journal of the American Society of Nephrology. 35(1). 41–55. 7 indexed citations
6.
Li, Jinyu, et al.. (2023). Oncogenic dependency plays a dominant role in the immune response to cancer. Proceedings of the National Academy of Sciences. 120(41). e2308635120–e2308635120. 4 indexed citations
7.
Ischenko, Irene, Stephen D’Amico, Manisha Rao, et al.. (2021). KRAS drives immune evasion in a genetic model of pancreatic cancer. Nature Communications. 12(1). 1482–1482. 122 indexed citations
8.
Petrenko, Oleksi, Jinyu Li, Velasco Cimica, et al.. (2021). IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3. PLoS ONE. 16(3). e0247394–e0247394. 8 indexed citations
9.
D’Amico, Stephen, Jiaqi Shi, Benjamin L. Martin, et al.. (2018). STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis. Genes & Development. 32(17-18). 1175–1187. 57 indexed citations
10.
Alexander, David N., Andrew J. Cutler, Stephen D’Amico, et al.. (2017). Dextromethorphan/Quinidine Improved Symptoms of Pseudobulbar Affect Irrespective of Concomitant Antidepressant Use (P6.210). Neurology. 88(16_supplement). 1 indexed citations
11.
D’Amico, Stephen, David N. Alexander, Andrew J. Cutler, et al.. (2017). Safety and Tolerability of Dextromethorphan/Quinidine in Older Patients. American Journal of Geriatric Psychiatry. 25(3). S142–S142. 2 indexed citations
12.
13.
Hammond, Flora M., David N. Alexander, Andrew J. Cutler, et al.. (2016). PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology. 16(1). 160–160. 27 indexed citations
14.
Doody, Rachelle S., Stephen D’Amico, Andrew J. Cutler, et al.. (2015). An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results. CNS Spectrums. 21(6). 450–459. 10 indexed citations
15.
D’Amico, Stephen & William F. Collins. (2012). External urethral sphincter motor unit recruitment patterns during micturition in the spinally intact and transected adult rat. Journal of Neurophysiology. 108(9). 2554–2567. 20 indexed citations
16.
D’Amico, Stephen, et al.. (2010). Quantification of external urethral sphincter and bladder activity during micturition in the intact and spinally transected adult rat. Experimental Neurology. 228(1). 59–68. 25 indexed citations
17.
Guo, Yuanjian, Urszula Golebiewska, Stephen D’Amico, & Suzanne Scarlata. (2010). The Small G Protein Rac1 Activates Phospholipase Cδ1 through Phospholipase Cβ2. Journal of Biological Chemistry. 285(32). 24999–25008. 13 indexed citations
18.
Koukopoulos, Alexia E., et al.. (1992). [Mixed depressive syndrome].. PubMed. 18 Spec No 1. 19–21. 40 indexed citations
19.
Moss, Rachel, et al.. (1987). Mental dysfunction as a sign of organic illness in the elderly.. PubMed. 42(12). 35–42. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Andermarcher Breakdown of academic impact, for papers by Wenzhong Zhu Breakdown of academic impact, for papers by Eva Schmidt Breakdown of academic impact, for papers by Claudio Catalani Breakdown of academic impact, for papers by Marta Szybowska Breakdown of academic impact, for papers by Yi-Chien Yang Breakdown of academic impact, for papers by Hesong Jiang Breakdown of academic impact, for papers by Christopher W. Perrett Breakdown of academic impact, for papers by Maryline Favier Breakdown of academic impact, for papers by Qiu-Jie Zhao
Rankless by CCL
2026